Please see annexed enclosure.
LAURUSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Laurus Labs Ltd has disclosed its upcoming investor engagement schedule under SEBI's Regulation 30. The company will participate in two healthcare-focused investor conferences in Hyderabad: BofA Healthcare Tour on June 5, 2026, and Macquarie Healthcare Tour on June 10, 2026. Both meetings are scheduled as in-person interactions. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be shared during these meetings, addressing regulatory compliance concerns.
This is a routine disclosure showing active institutional investor outreach. While not directly impacting financials, increased investor engagement with major financial institutions like BofA and Macquarie could signal growing institutional interest in the pharma company.